Patents by Inventor Thomas W. Myers

Thomas W. Myers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11162904
    Abstract: An inspection tester for testing a surface for suspected explosive substances includes a body unit, a breakable ampoule carried by the body unit, and an ionic explosive detecting reagent in the breakable ampoule wherein the body unit and the breakable ampoule are positioned to deliver the ionic explosive detecting reagent to the surface for testing the surface for the suspected explosive substances. The ionic explosive detecting reagent is a salt in a liquid state.
    Type: Grant
    Filed: July 12, 2019
    Date of Patent: November 2, 2021
    Assignee: Lawrence Livermore National Security, LLC
    Inventors: John G. Reynolds, Lara D. Leininger, Thomas W. Myers
  • Patent number: 11048499
    Abstract: A system includes: a physical communication interface, hardware data storage, and validation circuitry. The validation circuitry may load an infrastructure definition and, based on the enablement flag, determine whether the test definition is enabled or non-enabled. The validation circuitry may further exclude the test definition when the test definition is not enabled, and report an error to an operator interface display when the test definition was excluded. The validation circuitry may further generate a call to the serverless infrastructure provider when the test definition is enabled, and receive a resource description in response. The validation circuitry may terminate the provisioned resource when the expected configuration is not included within the resource description. The validation circuitry may mark the infrastructure definition as validated when the expected configuration is included within the resource description.
    Type: Grant
    Filed: June 14, 2019
    Date of Patent: June 29, 2021
    Assignee: Accenture Global Solutions Limited
    Inventors: Roger Foskett, Thomas W. Myers
  • Publication number: 20210010941
    Abstract: An inspection tester for testing a surface for suspected explosive substances includes a body unit, a breakable ampoule carried by the body unit, and an ionic explosive detecting reagent in the breakable ampoule wherein the body unit and the breakable ampoule are positioned to deliver the ionic explosive detecting reagent to the surface for testing the surface for the suspected explosive substances. The ionic explosive detecting reagent is a salt in a liquid state.
    Type: Application
    Filed: July 12, 2019
    Publication date: January 14, 2021
    Inventors: John G. Reynolds, Lara D. Leininger, Thomas W. Myers
  • Patent number: 10724016
    Abstract: Disclosed are mutant DNA polymerases having increased 3?-mismatch discrimination relative to a corresponding, unmodified polymerase. The mutant polymerases are useful in a variety of disclosed primer extension methods. Also disclosed are related compositions, including recombinant nucleic acids, vectors, and host cells, which are useful, e.g., for production of the mutant DNA polymerases.
    Type: Grant
    Filed: May 1, 2018
    Date of Patent: July 28, 2020
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Fred Reichert, Keith Bauer, Thomas W. Myers, Nancy J. Schoenbrunner, Joseph San Filippo
  • Patent number: 10719311
    Abstract: A library may include serverless artifacts that support execution of respective serverless functions. For each of the artifacts, a build parameter may have a library artifact identifier, a respective execution environment specifier, and a respective component specifier. An infrastructure realization knowledge base may define an environment mapping for each of the serverless artifacts. A build execution engine may create a build script that can be executed on a serverless artifact build infrastructure. To implement the build script the build script may be transmitted over a build communication channel to a cloud based serverless infrastructure provider.
    Type: Grant
    Filed: September 8, 2017
    Date of Patent: July 21, 2020
    Assignee: Accenture Global Solutions Limited
    Inventors: Roger Foskett, Thomas W. Myers
  • Patent number: 10689718
    Abstract: A method of simultaneously amplifying genotypes 1, 2, 3 and/or 4 of HEV is disclosed comprising amplifying the genotypes 1, 2, 3 and/or 4 of HEV with one single none-degenerate forward primer partially overlapping the 5?UTR region of HEV and at least one reverse primer. Also disclosed are related methods comprising a probe, and kits for the detection of genotypes 1, 2, 3 and/or 4 of HEV.
    Type: Grant
    Filed: June 2, 2017
    Date of Patent: June 23, 2020
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Hermann Leying, Thomas W. Myers, Nicolas Newton, Eberhard Russmann, Joseph San Filippo, Nancy Schoenbrunner, Heike Wilts, Xiaoning Wu, Karen K. Y. Young, Dirk Zimmermann
  • Patent number: 10647966
    Abstract: Disclosed are mutant DNA polymerases having increased 3?-mismatch discrimination relative to a corresponding, unmodified polymerase. The mutant polymerases are useful in a variety of disclosed primer extension methods. Also disclosed are related compositions, including recombinant nucleic acids, vectors, and host cells, which are useful, e.g., for production of the mutant DNA polymerases.
    Type: Grant
    Filed: January 5, 2018
    Date of Patent: May 12, 2020
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Fred Reichert, Keith Bauer, Thomas W. Myers
  • Patent number: 10647967
    Abstract: Disclosed are mutant DNA polymerases having increased 3?-mismatch discrimination relative to a corresponding, unmodified polymerase. The mutant polymerases are useful in a variety of disclosed primer extension methods. Also disclosed are related compositions, including recombinant nucleic acids, vectors, and host cells, which are useful, e.g., for production of the mutant DNA polymerases.
    Type: Grant
    Filed: January 11, 2018
    Date of Patent: May 12, 2020
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Fred Reichert, Keith Bauer, Thomas W. Myers
  • Patent number: 10597644
    Abstract: Disclosed are DNA polymerases having increased reverse transcriptase efficiency, mismatch tolerance, extension rate and/or tolerance of RT and polymerase inhibitors relative to a corresponding, unmodified polymerase. The polymerases are useful in a variety of disclosed primer extension methods. Also disclosed are related compositions, including recombinant nucleic acids, vectors, and host cells, which are useful, e.g., for production of the DNA polymerases.
    Type: Grant
    Filed: March 17, 2017
    Date of Patent: March 24, 2020
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Keith Bauer, Thomas W. Myers, Fred Reichert, Joseph San Filippo, Rachel Shahinian, Shawn Suko
  • Patent number: 10590400
    Abstract: Disclosed are mutant DNA polymerases having increased 3?-mismatch discrimination relative to a corresponding, unmodified polymerase. The mutant polymerases are useful in a variety of disclosed primer extension methods. Also disclosed are related compositions, including recombinant nucleic acids, vectors, and host cells, which are useful, e.g., for production of the mutant DNA polymerases.
    Type: Grant
    Filed: January 4, 2018
    Date of Patent: March 17, 2020
    Assignee: Roch Molecular Systems, Inc.
    Inventors: Keith Bauer, Fred Reichert, Thomas W. Myers
  • Patent number: 10563182
    Abstract: Disclosed are mutant DNA polymerases having increased 3?-mismatch discrimination relative to a corresponding, unmodified polymerase. The mutant polymerases are useful in a variety of disclosed primer extension methods. Also disclosed are related compositions, including recombinant nucleic acids, vectors, and host cells, which are useful, e.g., for production of the mutant DNA polymerases.
    Type: Grant
    Filed: November 22, 2017
    Date of Patent: February 18, 2020
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Fred Reichert, Keith Bauer, Thomas W. Myers
  • Patent number: 10544404
    Abstract: Disclosed are mutant DNA polymerases having increased 3?-mismatch discrimination relative to a corresponding, unmodified polymerase. The mutant polymerases are useful in a variety of disclosed primer extension methods. Also disclosed are related compositions, including recombinant nucleic acids, vectors, and host cells, which are useful, e.g., for production of the mutant DNA polymerases.
    Type: Grant
    Filed: December 6, 2017
    Date of Patent: January 28, 2020
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Keith Bauer, Fred Reichert, Thomas W. Myers
  • Patent number: 10487315
    Abstract: Provided are DNA polymerases having increased reverse transcriptase efficiency relative to a corresponding, unmodified polymerase. The polymerases are useful in a variety of primer extension methods. Also provided are related compositions, including recombinant nucleic acids, vectors, and host cells, which are useful, e.g., for production of the DNA polymerases.
    Type: Grant
    Filed: September 20, 2017
    Date of Patent: November 26, 2019
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Keith Bauer, Thomas W. Myers, Shawn Suko
  • Publication number: 20190318312
    Abstract: Successfully deploying resources into the cloud is a constantly increasing technical challenge as more cloud service providers emerge, each offering disparate computing platforms, services, assets, supported technical components, and other features, including serverless execution. An infrastructure build and collaboration architecture for serverless execution environments solves the technically complex challenges around allowing developers to work independently in physically separated locations. To this end, the architecture allows shared object repositories to be brought together when required. The architecture performs deep validation of the infrastructure built for the developer.
    Type: Application
    Filed: June 14, 2019
    Publication date: October 17, 2019
    Applicant: Accenture Global Solutions Limited
    Inventors: Roger Foskett, Thomas W. Myers
  • Patent number: 10360025
    Abstract: Successfully deploying resources into the cloud is a constantly increasing technical challenge as more cloud service providers emerge, each offering disparate computing platforms, services, assets, supported technical components, and other features, including serverless execution. An infrastructure build and collaboration architecture for serverless execution environments solves the technically complex challenges around allowing developers to work independently in physically separated locations. To this end, the architecture allows shared object repositories to be brought together when required and provides an object-model for defining resources without requiring the developer to have complete expert knowledge of the target deployment language. The architecture also enforces policy for both software design and infrastructure, and performs deep validation of the infrastructure built for the developer.
    Type: Grant
    Filed: September 8, 2017
    Date of Patent: July 23, 2019
    Assignee: Accenture Global Solutions Limited
    Inventors: Roger Foskett, Thomas W. Myers
  • Patent number: 10294462
    Abstract: Disclosed are DNA polymerases having increased reverse transcriptase efficiency relative to a corresponding, unmodified polymerase. The polymerases are useful in a variety of disclosed primer extension methods. Also disclosed are related compositions, including recombinant nucleic acids, vectors, and host cells, which are useful, e.g., for production of the DNA polymerases.
    Type: Grant
    Filed: January 4, 2018
    Date of Patent: May 21, 2019
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Keith Bauer, Thomas W. Myers, Shawn Suko
  • Publication number: 20190079751
    Abstract: Successfully deploying resources into the cloud is a constantly increasing technical challenge as more cloud service providers emerge, each offering disparate computing platforms, services, assets, supported technical components, and other features, including serverless execution. An infrastructure build and collaboration architecture for serverless execution environments solves the technically complex challenges around allowing developers to work independently in physically separated locations. To this end, the architecture allows shared object repositories to be brought together when required and provides an object-model for defining resources without requiring the developer to have complete expert knowledge of the target deployment language. The architecture also enforces policy for both software design and infrastructure, and performs deep validation of the infrastructure built for the developer.
    Type: Application
    Filed: September 8, 2017
    Publication date: March 14, 2019
    Inventors: Roger Foskett, Thomas W. Myers
  • Publication number: 20190079750
    Abstract: Successfully deploying resources into the cloud is a constantly increasing technical challenge as more cloud service providers emerge, each offering disparate computing platforms, services, assets, supported technical components, and other features. Relatively recently, cloud service providers have introduced serverless execution frameworks that eliminate the need for statically provisioned servers and instead provision and execute functions dynamically. A function library build architecture for serverless execution environments solves the technically complex challenges with successfully building functions that must run in serverless execution environments, and making those function available in a function library.
    Type: Application
    Filed: September 8, 2017
    Publication date: March 14, 2019
    Inventors: Roger Foskett, Thomas W. Myers
  • Patent number: 10144918
    Abstract: Disclosed are mutant DNA polymerases having increased 3?-mismatch discrimination relative to a corresponding, unmodified polymerase. The mutant polymerases are useful in a variety of disclosed primer extension methods. Also disclosed are related compositions, including recombinant nucleic acids, vectors, and host cells, which are useful, e.g., for production of the mutant DNA polymerases.
    Type: Grant
    Filed: August 16, 2017
    Date of Patent: December 4, 2018
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Fred Reichert, Keith Bauer, Thomas W. Myers
  • Patent number: 10131887
    Abstract: Disclosed are mutant DNA polymerases having increased 3?-mismatch discrimination relative to a corresponding, unmodified polymerase. The mutant polymerases are useful in a variety of disclosed primer extension methods. Also disclosed are related compositions, including recombinant nucleic acids, vectors, and host cells, which are useful, e.g., for production of the mutant DNA polymerases.
    Type: Grant
    Filed: November 7, 2017
    Date of Patent: November 20, 2018
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Fred Reichert, Keith Bauer, Thomas W. Myers